HealthTree Logo
search more_vert
person Sign In / Create Account
What are Bispecific Antibodies and How are They Used in Treating Multiple Myeloma?
Posted: May 03, 2022
What are Bispecific Antibodies and How are They Used in Treating Multiple Myeloma? image

HealthTree University: Immunotherapy Antibodies 2/2

What are bispecific antibodies and how are they used in treating multiple myeloma? Find out below to see if bispecific antibodies are being used in myeloma and if there any bispecific antibodies that are FDA approved. We've assembled this course which features the top world experts on immunotherapy to teach you about these latest advances in myeloma research. You can watch the entire course on HealthTree University.

15.05    What are bispecific antibodies?


15.06    Are there any bispecific antibodies that are FDA approved?


We’d like to thank our faculty who donated their time in creating these videos, including:

  • Ravi Vij, MD, MBA
  • David Vesole, MD, PhD
  • Luciano Costa, MD, PhD
  • Peter Voorhees, MD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!


The author Clark Ahlstrom

about the author
Clark Ahlstrom

Clark Ahlstrom is the video team manager for HealthTree University and oversees video production of new HealthTree University videos. He started working at the foundation together with Jenny Ahlstrom, his mother, after her myeloma diagnosis.

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Bristol Myers Squibb

Follow Us

facebook instagram linkedin tiktok youtube